pharma-company /Medicinal products /Active ingredients

Rx · PZN 16398714

HARVONI 33,75 mg/150 mg befilmtes granules in sachet

German trade nameHARVONI 33,75 mg-150 mg befilmtes Granulat in Beutel

Active ingredientSofosbuvir and ledipasvirSubstance (DE)Sofosbuvir und LedipasvirPharmaceutical formGranules

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

~ €12,188

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for HARVONI 33,75 mg/150 mg befilmtes granules in sachet.

Review purchasing terms

HARVONI 33,75 mg/150 mg befilmtes granules in sachet contains the active ingredient Sofosbuvir and ledipasvir (German Sofosbuvir und Ledipasvir) and comes as Granules. One pack size is recorded (PZN 16398714). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.

HARVONI 33,75 mg/150 mg befilmtes granules in sachet was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

More products containing Sofosbuvir and ledipasvir

HARVONI 90 mg/400 mg film-coated tablets0.5HARVONI 45 mg/200 mg befilmtes granules in sachet0.0HARVONI 45 mg/200 mg film-coated tablets0.0
Active ingredient overview: Sofosbuvir and ledipasvir →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.